CAS 945721-28-8

Daratumumab

CAS: 945721-28-8

Daratumumab is a human monoclonal antibody that targets CD38 a cell surface protein that is overexpressed on multiple myeloma MM) cells.

Purezza: 98.50% - 98.60%

Colore e forma: Liquid

Peso molecolare: 145.26 kDa

Ref: TM-T9918

Daratumumab - 20mg/ml in buffer

CAS: 945721-28-8

Monoclonal antibody against CD38; treatment for multiple myeloma

Purezza: Min. 95 Area-%

Colore e forma: Powder

Ref: 3D-BD165586